A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . (ICCRN RCT2)

This study has been terminated.
Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Interstitial Cystitis
			Painful Bladder Syndrome
2		Additional conditions recognized in this trial
			Cystitis
			Cystitis, Interstitial
			Syndrome
3		More general conditions related to this trial
			Disease
			Pathologic Processes
			Urinary Bladder Diseases
			Urologic Diseases
4		Interventions listed in this trial
			Mycophenolate Mofetil
			Mycofenolate Mofetil (MMF)
			Placebo
5		Additional drug interventions recognized in this trial
			Mycophenolic Acid
6		More general drug interventions related to this trial
			Antibiotics, Antineoplastic
			Antineoplastic Agents
			Enzyme Inhibitors
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)